Cargando…
A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer
The purpose of the study was to determine the maximum-tolerated dose (MTD) of oral capecitabine, combined with concurrent, standard preoperative pelvic radiotherapy, when given twice daily, from Monday to Friday throughout the course of radiotherapy, for locally advanced potentially resectable recta...
Autores principales: | Ngan, S Y K, Michael, M, Mackay, J, McKendrick, J, Leong, T, Lim Joon, D, Zalcberg, J R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747703/ https://www.ncbi.nlm.nih.gov/pubmed/15305186 http://dx.doi.org/10.1038/sj.bjc.6602106 |
Ejemplares similares
-
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
por: García, Margarita, et al.
Publicado: (2015) -
Phase II trial evaluating the feasibility of interdigitating folfox with chemoradiotherapy in locally advanced and metastatic rectal cancer
por: Michael, M, et al.
Publicado: (2014) -
Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial
por: Loi, S, et al.
Publicado: (2005) -
A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer
por: Michael, M, et al.
Publicado: (2009) -
Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
por: Koeberle, D, et al.
Publicado: (2008)